title: Outcomes of Surgical Resection of T1bN0 Esophageal Cancer and Assessment of Endoscopic Mucosal Resection for Identifying Low-Risk Cancers Appropriate for Endoscopic Therapy.
abstract: Invasive esophageal cancers have been managed historically with esophagectomy. Low-risk T1b patients are being proposed for nonsurgical management. The purpose of this study was to evaluate the ability of endoscopic mucosal resections (EMR) to identify low-risk T1b patients and to review surgical treatment outcomes for T1b cancer.
  
  
  
  All esophageal cancer patients, in an institutional review board-approved prospective database, between 2000 and 2013 with clinical stage (cT1bN0), pathological stage (pT1bN0), and no neoadjuvant therapy were retrospectively reviewed.
  
  
  
  Fifty-one patients, 38 pT1b and 13 cT1b, were assessed. All cT1b had preoperative EMR and five were found to be understaged at esophagectomy. pT1bN0 patients had a mean age of 66 years, mean BMI of 30, and 95 % had adenocarcinoma. Thirty-eight pT1bN0 patients underwent esophagectomy with a median hospital length of stay (LOS) of 9 days. Complications occurred in 14 patients, but 71 % were minor (Accordion score 1-2). In-hospital 30- and 90-day mortality was zero. EMR specimens were re-reviewed to assess low-risk criteria. Degree of differentiation and the presence of lymphovascular invasion could be assessed in all EMR specimens; however, assessment of submucosal invasion limited to the superficial submucosal layer could not be determined in the majority of cases. Kaplan-Meier 5-year overall survival in pT1bN0 patients was 78.7 %.
  
  
  
  Clinical staging of superficial esophageal cancer can be inaccurate especially in submucosal tumors. EMR should be routinely used for preoperative staging. Healthy patients with clinical tumor stage greater than cT1a should undergo multidisciplinary review and be considered for surgical resection.
authors.affiliation: Department of Thoracic Surgery, Virginia Mason Medical Center, Seattle, WA, USA.
authors.forename: Kamran
authors.initials: K
authors.lastname: Mohiuddin
authors.affiliation: Department of Pathology, Virginia Mason Medical Center, Seattle, WA, USA.
authors.forename: Russell
authors.initials: R
authors.lastname: Dorer
authors.affiliation: Department of Thoracic Surgery, Virginia Mason Medical Center, Seattle, WA, USA.
authors.forename: Mustapha A
authors.initials: MA
authors.lastname: El Lakis
authors.affiliation: Department of Pathology, Virginia Mason Medical Center, Seattle, WA, USA.
authors.forename: Hejin
authors.initials: H
authors.lastname: Hahn
authors.affiliation: Department of Thoracic Surgery, Virginia Mason Medical Center, Seattle, WA, USA.
authors.forename: James
authors.initials: J
authors.lastname: Speicher
authors.affiliation: Department of Thoracic Surgery, Virginia Mason Medical Center, Seattle, WA, USA.
authors.forename: Michal
authors.initials: M
authors.lastname: Hubka
authors.affiliation: Department of Thoracic Surgery, Virginia Mason Medical Center, Seattle, WA, USA. donald.low@virginiamason.org.
authors.forename: Donald E
authors.initials: DE
authors.lastname: Low
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology* / Q000601:surgery; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000601:surgery; D000069916:Endoscopic Mucosal Resection / Q000401:mortality*; D004938:Esophageal Neoplasms / Q000473:pathology* / Q000601:surgery; D016629:Esophagectomy / Q000401:mortality*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D012189:Retrospective Studies; D015996:Survival Rate